These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
4.7 (196) · $ 4.50 · In stock
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
Prescribing Information Ozempic® (semaglutide) injection 0.5 mg or 1 mg
Does Medicare cover Ozempic?
Prescribing Information Ozempic® (semaglutide) injection 0.5 mg or 1 mg
Prescribing Information Ozempic® (semaglutide) injection 0.5 mg or 1 mg
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
Dosing & Prescribing Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
Dosing & Prescribing Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
Dosing & Prescribing Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017
These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017